RxDoctor Payments DataLook up a doctor →

Michelle Gilliland

Adult Health · Amherst, NYNPI 1619129764

Payments from drug & device makers

$24,612in general payments, 2019–2025

Across 941 payments — averaging $26.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$9K
  • AbbVie$3K
  • MDD US Operations, LLC$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Impel Pharmaceuticals Inc.$939
  • Amgen$901
  • plus $9K from 49 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axsome Therapeutics, Inc.19$8,708
AbbVie(2 entities)160$3,069
MDD US Operations, LLC36$1,227
Teva Pharmaceuticals USA, Inc.57$1,088
Impel Pharmaceuticals Inc.61$939
Amgen(2 entities)43$901
UCB, Inc.35$806
Biohaven Pharmaceuticals, Inc.52$659
Biohaven Pharmaceutical Holding Company Ltd.87$650
Tonix Medicines, Inc.64$649
Lundbeck LLC36$525
Scilex Pharmaceuticals Inc.63$465
Lilly USA, LLC27$460
AstraZeneca(2 entities)12$311
Pfizer19$307
Upsher-smith Laboratories LLC20$300
SK Life Science, Inc.7$293
Azurity Pharmaceuticals, Inc.13$235
Neurocrine Biosciences, Inc.13$233
TG Therapeutics, Inc.3$230
Jazz Pharmaceuticals Inc.7$223
Currax Pharmaceuticals LLC13$211
Johnson & Johnson(2 entities)4$183
Eisai Inc.6$141
Abbott2$137
Supernus Pharmaceuticals, Inc.8$134
CSL Behring6$132
Catalyst Pharmaceuticals, Inc.6$129
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$125
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)7$123
Grifols USA, LLC4$87
Tanabe Pharma America, Inc.5$83
Amneal Pharmaceuticals LLC5$77
Impel Pharmaceuticals LLC4$75
Vifor Pharma, Inc.1$67
Novartis4$64
Otsuka America Pharmaceutical, Inc.3$63
Averitas Pharma Inc.3$62
Harmony Biosciences LLC2$56
Banner Life Sciences, LLC3$50
Xeris Pharmaceuticals, Inc.2$36
Arbor Pharmaceuticals, Inc.2$33
Octapharma USA, Inc.2$32
Collegium Pharmaceutical, Inc.2$27
Novocure Inc.2$26
Biogen1$23
Mirum Pharmaceuticals, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$22
Sarepta Therapeutics, Inc.1$21
Acorda Therapeutics, Inc1$21
Kyowa Kirin, Inc.1$21
Novo Nordisk1$18
Bristol Myers Squibb1$15
Amylyx Pharmaceuticals, Inc.1$14
GE HealthCare1$3

How this compares

$24,612 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York →

Medicare billing

Part B allowed, 2024
$98,328
Medicare patients
70
Services billed
12,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Amherst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →